Target intelligence / Profile preview

Interleukin-18 receptor accessory protein (IL-18RAP) (IL-18RAP)

Target
IL-18RAP
Molecular classification
Receptor, Interleukin-1 receptor family
01

Overview

Interleukin-18 receptor accessory protein (IL-18RAP), also known as IL-18 receptor beta, is a transmembrane protein that functions as the signaling subunit of the IL-18 receptor complex (UniProt, Q99467). While the IL-18 receptor alpha subunit (IL-18R1) provides the initial binding site for the IL-18 ligand, IL-18RAP is essential for forming a high-affinity heterotrimeric complex that initiates intracellular signaling (NCBI Gene, 8807). Upon ligand binding and recruitment of IL-18RAP, the complex activates the MyD88-dependent pathway, leading to the activation of NF-kappaB and mitogen-activated protein kinases (MAPK) (PubMed, 10653850). This signaling cascade is a primary driver for the production of interferon-gamma (IFN-gamma) in T cells and natural killer (NK) cells, which is critical for the Type 1 immune response (StatPearls, NBK545159). Dysregulation of IL-18RAP signaling is strongly associated with various inflammatory and autoimmune diseases, including Celiac disease, Crohn's disease, and rheumatoid arthritis. Therapeutic targeting of the IL-18/IL-18RAP axis is an active area of research, with drugs like Tadekinig alfa and GSK1070806 designed to neutralize the pathway's pro-inflammatory effects (, NCT03664037). Although most current clinical candidates target the IL-18 ligand, IL-18RAP remains a significant potential target for small molecules or antibodies aimed at disrupting the receptor complex assembly. The target's role in mediating chronic inflammation makes it a valuable focus for biotech analysts evaluating treatments for refractory autoimmune conditions.

Other names
IL-18 receptor betaIL-18R-betaIL-18RbetaIL-1R7ACPLInterleukin-1 receptor 7
02

Mechanism of action

Inhibition of the IL-18 signaling pathway by preventing the formation of the active IL-18/IL-18R1/IL-18RAP signaling complex.

03

Biological functions

Signal transductionImmune responseCytokine-mediated signalingInterferon-gamma production
04

Disease associations

InflammationCeliac diseaseCrohn's diseaseRheumatoid arthritisAsthmaType 1 diabetes
05

Safety considerations

Increased risk of infectionImmunosuppressionPotential impact on host defense against intracellular pathogens
06

Interacting drugs

2 more in the full profile.

07

Biomarkers

Interferon-gamma (IFN-gamma) levelsIL-18 levelsCXCL9CXCL10

Source types: Trial registry. Sources are available to Gosset users. Log in to see them.

Beyond the preview

Go deeper on Interleukin-18 receptor accessory protein (IL-18RAP) (IL-18RAP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Interleukin-18 receptor accessory protein (IL-18RAP) (IL-18RAP).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call